CIS
JUNO

Capital International Sarl’s Juno Therapeutics, Inc. JUNO Stock Holding History

Capital International Sarl’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-173,216
Closed -$7.92M – 143
2017
Q4 		$7.92M Buy
173,216
+316
+0.2% +$15.8K 0.74% 44
2017
Q3 		$7.76M Buy
+172,900
New +$5.89M 0.64% 48

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Capital International Sarl's JUNO Position: Q1 2018 in Review

Capital International Sarl sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 173,216 shares — an estimated $7.92M sold.

Capital International Sarl first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $7.92M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Capital International Sarl reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Capital International Sarl sold 173,216 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $7.92M.
  • Capital International Sarl first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Capital International Sarl's Juno Therapeutics, Inc. position peaked at $7.92M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Capital International Sarl's 13F filing for Q1 2018, filed 15 May 2018.